Brentuximab Vedotin May Cut Radiation Use in Pediatric Hodgkin Lymphoma

Cancer Discovery ◽

10.1158/2159-8290.cd-rw2021-058 ◽

2021 ◽

Keyword(s):

Hodgkin Lymphoma ◽

Brentuximab Vedotin ◽

Pediatric Hodgkin Lymphoma ◽

Download Full-text

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Case Medical Research ◽

10.31525/ct1-nct04213209 ◽

2019 ◽

Author(s):

Keyword(s):

T Cell ◽

Drug Use ◽

Hodgkin Lymphoma ◽

Intravenous Infusion ◽

Cell Lymphoma ◽

Brentuximab Vedotin ◽

T Cell Lymphoma ◽

Peripheral T Cell Lymphoma ◽

Pediatric Hodgkin Lymphoma

Download Full-text

SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL)

Hematological Oncology ◽

10.1002/hon.25_2629 ◽

2019 ◽

Vol 37 ◽

pp. 55-56

Author(s):

M. Metzger ◽

C. Mauz-Körholz ◽

J. Flerlage ◽

J. Bartelt ◽

A. Billett ◽

...

Keyword(s):

High Risk ◽

Hodgkin Lymphoma ◽

Brentuximab Vedotin ◽

Pediatric Hodgkin Lymphoma

Download Full-text

A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients who received autologuos stem cell transplantation (ASCT).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e21002 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e21002-e21002

Author(s):

Nurdan Tacyildiz ◽

Emel Unal ◽

Gulsan Yavuz ◽

Handan Dincaslan ◽

Gulsah Tanyildiz ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Salvage Therapy ◽

Brentuximab Vedotin ◽

Pediatric Hodgkin Lymphoma

Download Full-text

A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric hodgkin lymphoma patients before and after stem cell transplantation

The Turkish Journal of Pediatrics ◽

10.24953/turkjped.2019.05.005 ◽

2019 ◽

Vol 61 (5) ◽

pp. 671 ◽

Author(s):

Nurdan Taçyıldız ◽

Hikmet Gülşah Tanyıldız ◽

Emel Ünal ◽

Handan Dinçaslan ◽

Fikret Asarcıklı ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Salvage Therapy ◽

Brentuximab Vedotin ◽

Pediatric Hodgkin Lymphoma ◽

Before And After

Download Full-text

T023 (0106) SAFETY AND EARLY RESPONSE TO THE FIRST 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL)

10.1097/01.hs9.0000547935.17200.58 ◽

2018 ◽

Vol 2 (S3) ◽

pp. 36 ◽

Keyword(s):

High Risk ◽

Hodgkin Lymphoma ◽

Early Response ◽

Brentuximab Vedotin ◽

Pediatric Hodgkin Lymphoma

Download Full-text

BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON-BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL

Hematological Oncology ◽

10.1002/hon.2437_69 ◽

2017 ◽

Vol 35 ◽

pp. 81-82 ◽

Author(s):

S.I. Park ◽

O. Olajide ◽

N.M. Reddy ◽

L.E. Budde ◽

N. Ghosh ◽

...

Keyword(s):

Clinical Trial ◽

Hodgkin Lymphoma ◽

Brentuximab Vedotin ◽

Phase 2 ◽

Limited Stage ◽

Phase 2 Clinical Trial ◽

Download Full-text

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Klinische Pädiatrie ◽

10.1055/s-0034-1371160 ◽

2014 ◽

Vol 226 (02) ◽

Author(s):

R Zhou ◽

A Ng ◽

R Weathers ◽

A McDonald ◽

W Leisenring ◽

...

Keyword(s):

Radiation Exposure ◽

Hodgkin Lymphoma ◽

Reduce Radiation Exposure ◽

Normal Tissues ◽

Pediatric Hodgkin Lymphoma ◽

Lymphoma Therapy

Download Full-text

Immunological Status of the Host in Aspect of Epstein-Barr Virus Latency in Pediatric Hodgkin Lymphoma

Klinische Pädiatrie ◽

10.1055/s-0034-1371105 ◽

2014 ◽

Vol 226 (02) ◽

Author(s):

T Klekawka ◽

W Balwierz

Keyword(s):

Hodgkin Lymphoma ◽

Epstein Barr Virus ◽

Immunological Status ◽

Virus Latency ◽

Pediatric Hodgkin Lymphoma ◽

Download Full-text

The GATLA (Argentinian Collaborative Group) experience through international cooperation in Pediatric Hodgkin Lymphoma (HL)

10.1055/s-0040-1701830 ◽

2020 ◽

Author(s):

D Veron ◽

P Streitenberger ◽

D Freigeiro ◽

M Castellanos ◽

M Metzger

Keyword(s):

Hodgkin Lymphoma ◽

International Cooperation ◽

Collaborative Group ◽

Pediatric Hodgkin Lymphoma ◽

Group Experience

Download Full-text

Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node Radiation

SSRN Electronic Journal ◽

10.2139/ssrn.3716895 ◽

2020 ◽

Author(s):

Monika Metzger ◽

Michael P. Link ◽

Amy L. Billett ◽

Jamie Flerlage ◽

John T. Lucas Jr. ◽

...

Keyword(s):

High Risk ◽

Hodgkin Lymphoma ◽

Pediatric Patients ◽

Brentuximab Vedotin ◽

Excellent Outcome

Download Full-text